Germin8 Ventures Names Dr. Ashlie L. Burkart as Chief Scientific Officer
Germin8 Ventures Names Dr. Ashlie L. Burkart as Chief Scientific Officer February 4, 2021 CHICAGO – Feb. 3, 2021 – Germin8 Ventures, a purpose-driven venture capital firm backing the founders of technology companies transforming the food system as a means of solving global challenges, today announced the appointment of physician-scientist Dr. Ashlie L Burkart, MD as Chief Scientific Officer. Drawing upon her deep pathology and research background, Dr. Burkart will play a key role in extending Germin8’s scientific capabilities and actively supporting Germin8 portfolio companies. As a d...